Jason Putorti – How Mint.com Acquired 1.5M+ Users Really good post on user acquisition for Mint. 

Seems like VC’s are starting to bring in more new folks again.  It’s refreshing to see. I think Venture is very much a young person’s job and it behooves firms to have a flow of really good, smart, scrappy young […]

I’m doing a little experiment with Myers Briggs analysis and founding teams.  I’d love to hear what others think. I’ve known about the Myers Briggs personality test for a while. By the way, I’m an INFJ – relatively weak on […]

This is a quick post that has been sitting in my draft folder too long. I watched Mike Maples‘ presentation about “Thunder Lizards” a little while back.  It was a good talk and hopefully I get to meet him in person soon.  Here’s […]

This is my first post on a series about CPG advertising and the internet.  I think that a massive shift in CPG advertising to the web is happening, and it’s one of mytop 3 trends of the next year.  What is puzzling to […]

In honor of SXSW, which I sadly missed this year, here are my predictions for the next big areas of innovation on the web in the near future.  I am going to completely ignore mobile and geo, since it’s an area […]

I wrote a post on Sunday about Why the VC Business is like a big game of Texas Hold’Em. As folks pointed out, it’s not a perfect analogy, but there are major similarities because of the interplay of skill and […]

There is a meme on Twitter about the similarities of VC’s and Product Managers. I commented that A big difference in the VC business is that it takes a lot longer to figure out if you are good, and you […]

Being a VC, it’s easy to fall out of touch with mainstream consumers.  I spend so much time with geeks and early adopters that I sometimes forget that most people have no idea what Foursquare, Blippy, or OMGPOP are.  Some […]

Continuations: The Future of Browser Plugins (Hint: Let’s Call them Apps) At Union Square Ventures we have backed a couple of companies that use browser plugins at the core of their services (Adaptive Blue, Zemanta). We have always been concerned […]